CardioKinetix raises $14.5M for catheter-based heart treatment
CardioKinetix, a Redwood City, Calif. life sciences startup working on a heart-failure treatment that could potentially help over a million patients, has raised a third round of funding, according to VentureWire.
The company’s procedure uses a catheter to strengthen parts of the heart, and protect areas damaged following heart attacks. The device is designed to be an alternative to a risky surgery typically only used in high-risk patients.
Previous investors Cutlass Capital, JPMorgan Partners and U.S. Venture… Continue Reading
Life sciences briefing: Friday, Aug. 31, 2007
Featured companies: Aryx Therapeutics, FlowCardia, Graftcath
FlowCardia raises $30M for artery roto-rooters — Sunnyvale, Calif.-based FlowCardia, a medical-device maker building catheter systems that bore holes in blood clots, raised $30 million in a third funding round. Investors included Gilde Healthcare Partners, Life Sciences Partners, Hambrecht & Quist Capital Management, New Science Ventures, Frazier Healthcare Ventures, JP Morgan Partners, Pappas Ventures, Rockport Venture Partners and Gold Hill Capital. The funding is intended to speed commercialization of the company’s… Continue Reading
Cleveland biotech Athersys raises $65M with reverse-merger
Athersys, a Cleveland, Ohio biotech, went public via reverse merger and raised $65 million in a private placement. The company’s release is here.
Founded in 1995, Athersys is active in a bewildering number of areas. Its lead product candidate is an appetite-suppressing drug that acts on a serotonin receptor in the brain called 5HT2c, and in general the company describes itself as focused on metabolic and neurological conditions. But it is also at work on an… Continue Reading
Xoft raises $33.2M for breast cancer treatment
Xoft, a Fremont Ca. developer of a treatment to reduce the recurrence of breast cancer, said it has raised $33.2 million in a fourth round of financing, and plans to treat its first patients.
See statement here.
The company says its Axxent Electronic Brachytherapy System “uses a miniaturized X-ray source that can deliver localized and targeted radiation treatment,” and can be used in pretty much any environment, including unshielded environments.
The company has now raised a total of… Continue Reading